ADDPI 2023_118 INADA vs Pankaj

In May 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the powerlifter Pankaj after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone).

Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Panel finds that the presence of a prohibited substance has been established in the Athlete's system and accordingly that he committed an anti-doping rule violation. The Panel determines that the Athlete had admitted the use of the prohibited substance.

Therefore the Panel decides on 16 August 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 10 May 2023.

Original document

Parameters

Legal Source
National Decisions
Date
16 August 2023
Arbitrator
Deka, Abantika
Dhanda, Vineet
Ghadlinge, Manik S.
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
Substances
19-norandrosterone
Nandrolone (19-nortestosterone)
Document type
Pdf file
Date generated
21 September 2023
Date of last modification
28 September 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin